ClinicalTrials.Veeva

Menu

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

H

Hacettepe University

Status

Enrolling

Conditions

Swallowing
Scleroderma (Limited and Diffuse)
Scleroderma, Localized
Scleroderma
Systemic Sclerosis (SSc)

Treatments

Other: Questionnaire application for child and adult scleroderma patients

Study type

Observational

Funder types

Other

Identifiers

NCT07182981
SBA 25/528

Details and patient eligibility

About

It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance.

Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.

Enrollment

50 estimated patients

Sex

All

Ages

7+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

For a child diagnosed with scleroderma:

Inclusion Criteria:

  • Cases diagnosed with scleroderma,
  • Cases aged 7-18 years will be included.

Exclusion Criteria:

  • Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
  • Cases that are not willing to participate in the study will be excluded.
  • Having participated in a regular exercise program for the past 3 months
  • Individuals who are not willing to participate in the study

For adults diagnosed with scleroderma:

Inclusion Criteria:

  • Individuals diagnosed with scleroderma,
  • Individuals over the age of 18 will be included.

Exclusion Criteria:

  • Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
  • Individuals who are not willing to participate in the study will be excluded.
  • Having participated in a regular exercise program for the past 3 months
  • Individuals who are not willing to participate in the study

Trial design

50 participants in 1 patient group

Cases diagnosed with scleroderma
Description:
Child and adult scleroderma patients who visited the rheumatology outpatient clinic at a university hospital will complete a questionnaire.
Treatment:
Other: Questionnaire application for child and adult scleroderma patients

Trial contacts and locations

1

Loading...

Central trial contact

Orkun Tüfekçi, PT, PhD(c)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems